Ketamine, Psilocybin and New Drug Therapies: The Webinar Video Replay
Uncategorized July 19, 2020 MJ Shareholders
On July 9th, California psychedelic attorneys Hilary Bricken (Los Angeles), Griffen Thorne (Los Angeles), Vince Sliwoski (Portland) and Jesse Mondry (Portland) hosted an interactive webinar to answer questions on the future of legalization and regulation of new drug therapies and alternative medicine, including:
- efforts to decriminalize and regulate psychedelics and other plant medicines
- federal and state controlled substances laws and regulations
- Drug Enforcement Administration regulation
- corporate practice of medicine issues and medical ventures
- intellectual property strategies, and
- much more
In case you couldn’t join, or if you would like to revisit some of the information, you can stream the webinar below.
[embedded content]
MJ Shareholders
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers
